Authors: WEBB A CUNNINGHAM D SCARFFE JH HARPER P NORMAN A JOFFE JK HUGHES M MANSI J FINDLAY M HILL A OATES J NICOLSON M HICKISH T OBRIEN M IVESON T WATSON M UNDERHILL C WARDLEY A MEEHAN M

Citation: A. Webb et al., RANDOMIZED TRIAL COMPARING EPIRUBICIN, CISPLATIN, AND FLUOROURACIL VERSUS FLUOROURACIL, DOXORUBICIN, AND METHOTREXATE IN ADVANCED ESOPHAGOGASTRIC CANCER, Journal of clinical oncology, 15(1), 1997, pp. 261-267

Authors: JOFFE JK PERREN TJ BRADLEY C PRIMROSE J HALLAM S WARD U ILLINGWORTH JM SELBY PJ

Citation: Jk. Joffe et al., A PHASE-II STUDY OF RECOMBINANT INTERFERON-BETA (R-HIFN-BETA 1A) IN COMBINATION WITH 5-FLUOROURACIL (5-FU) IN THE TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA, British Journal of Cancer, 75(3), 1997, pp. 423-426

Authors: JOFFE JK PATEL PM BANKS RE SELBY PJ

Citation: Jk. Joffe et al., CYTOKINES IN COMBINATION WITH CHEMOTHERAPY FOR ADVANCED RENAL-CARCINOMA - THE IMPORTANCE OF PATIENT SELECTION, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(5), 1996, pp. 309-313

Authors: JOFFE JK BANKS RE FORBES MA HALLAM S JENKINS A PATEL PM HALL GD VELIKOVA G ADAMS J CROSSLEY A JOHNSON PWM WHICHER JT SELBY PJ

Citation: Jk. Joffe et al., A PHASE-II STUDY OF INTERFERON-ALPHA, INTERLEUKIN-2 AND 5-FLUOROURACIL IN ADVANCED RENAL-CARCINOMA - CLINICAL-DATA AND LABORATORY EVIDENCE OF PROTEASE ACTIVATION, British Journal of Urology, 77(5), 1996, pp. 638-649

Authors: JOFFE JK BELL JBG DENHAM S ADSHEAD F MILLAR JL MILLAR BC

Citation: Jk. Joffe et al., G-CSF IS A MAJOR COMPONENT OF COLONY-STIMULATING ACTIVITY (CSA) IN THE PLASMA OF PATIENTS WITH MULTIPLE-MYELOMA AFTER TREATMENT WITH HIGH-DOSE MELPHALAN (HDM), Experimental hematology, 23(4), 1995, pp. 376-382